Ταυτότητα

Rifomycin O

Δεν αναφέρεται · C39H47NO14

01Ταυτότητα

Lazychem IDLC-37731
CAS RNΔεν αναφέρεται
PubChem CID73415874
Molecular formulaC39H47NO14
Molecular weight753.8 g/mol
IUPAC name[(2R,7'S,9'E,11'S,12'R,13'S,14'R,15'R,16'R,17'S,18'S,19'E,21'Z)-2',15',17'-trihydroxy-11'-methoxy-3',7',12',14',16',18',22'-heptamethyl-4,6',23',29'-tetraoxospiro[1,3-dioxolane-2,27'-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25-heptaene]-13'-yl] acetate
InChIKeyRAFHKEAPVIWLJC-TWYIRNIGSA-N

02Δομή και στερεοχημεία

Two-dimensional chemical structure of Rifomycin O
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 6 rings, includes aromatic atoms, includes aliphatic carbon, has 10 defined stereocentres. These statements are calculated from the published structure string.

Defined stereocentres10
Ring count6
Secondary amines0
Tertiary amines0
SMILESC[C@H]1/C=C/C=C(\C(=O)NC2=C[C@@]3(C4=C(C2=O)C(=C(C5=C4C(=O)[C@](O5)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)OCC(=O)O3)/C
InChIΔεν αναφέρεται

03Stereochemistry

The published structure contains 10 defined and 0 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres10Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 1,024Before symmetry reduction

Published same-connectivity configurations

3 records

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Κατάσταση στην Ινδία

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Ονόματα και σχέσεις

API και μητρικό φάρμακο

Δεν αναφέρεται

Ονόματα και σχέσεις

    06Πηγές